APYX MEDICAL CORP (APYX) Stock Income Statement
NASDAQ:APYX - US03837C1062 - Common Stock
2.08 USD
+0.02 (+0.97%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 46.51M | 48.10M | 52.35M | 44.51M | 48.52M | |||
| Minority Interest Expense | 34.00K | 96.00K | 137.00K | 90.00K | 30.00K | |||
| Cost Of Goods | 17.85M | 18.74M | 18.59M | 15.38M | 14.92M | |||
| Gross Profit | 28.67M | 29.36M | 33.76M | 29.13M | 33.60M | |||
| Operating Expenses | 40.97M | 48.20M | 53.71M | 52.69M | 48.05M | |||
| Research and Development | 3.89M | 5.08M | 4.84M | 4.54M | 4.32M | |||
| Selling, General, and Administrative Expenses | 37.09M | 43.13M | 48.87M | 48.15M | 43.73M | |||
| Operating Income | -12.31M | -18.84M | -19.95M | -23.56M | -14.45M | |||
| Interest Income/Expense | -4.60M | -4.30M | -1.56M | 140.00K | 0.00 | |||
| Other Income/Expense | -139.00K | -161.00K | 622.00K | 510.00K | -370.00K | |||
| Non Recurring Items | N/A | 0.00 | -396.00K | N/A | N/A | |||
| Income Before Taxes | -17.05M | -23.31M | -21.28M | -22.91M | -14.82M | |||
| Income Tax | 247.00K | 252.00K | -2.43M | 370.00K | 380.00K | |||
| Net Income | -17.26M | -23.46M | -18.71M | -23.18M | -15.17M | |||
| EBITDA | -11.75M | -18.25M | -19.26M | -22.67M | -13.55M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.45 | -0.66 | -0.54 | -0.67 | -0.44 | |||
| Non GAAP EPS | -0.45 | -0.67 | -0.62 | -0.67 | -0.44 | |||
| Statistics | ||||||||
| Gross Profit Margin | 61.63% | 61.04% | 64.49% | 65.45% | 69.25% | |||
| Profit Margin | -37.11% | -48.78% | -35.75% | -52.08% | -31.27% | |||
| Operating Profit Margin | -26.46% | -39.18% | -38.11% | -52.93% | -29.78% | |||
All data in USD